United States HR 3223: Pharmacy Benefit Manager Accountability Study Act of 2019

Status: Referred to the Subcommittee on Health. (as of 2019-06-13)

State: United States · Session: 116 · Bill: HR 3223

Subjects: Competition and antitrust, Congressional oversight, Consumer affairs, Drug therapy, Government studies and investigations, Health care costs and insurance, Health care coverage and access, Inflation and prices, Prescription drugs, User charges and fees

Sponsors: Roger W. Marshall, Cynthia Axne, Earl L. "Buddy" Carter, Peter Welch, Vicente Gonzalez

View United States HR 3223 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.